{
  "head": {
    "vars": [ "studyUri" , "label" , "title" , "activity" , "armUid" , "treatmentDrug" , "armLabel" , "drugLabel" , "drugUid" , "outcomeUids" , "studyGraphUri" ]
  } ,
  "results": {
    "bindings": [
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/eaea4081-8da1-4c5b-96e0-aa3077adebca" } ,
        "label": { "type": "literal" , "value": "TAK491-019 / NCT00696436" } ,
        "title": { "type": "literal" , "value": "An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension." } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/605c4e0a-5b6b-4121-93e5-c93ac69d3798" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8b0f8478-a1ae-490f-bf4d-2b5de33a2645" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/a769aafe-2edd-4526-a09a-459a28700c2e" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 80 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/33a0eff6-f392-4804-b480-558a25baf515, http://trials.drugis.org/entities/faa2ac02-647d-448b-9ef4-b3319057dfa3, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/728ad883-6c95-4725-8425-910cd491a135, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/500779e0-7f4c-4e01-97f4-dc38d36ac915, http://trials.drugis.org/entities/95396b3a-1854-4719-9312-a8340f959edb, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/0760feb2-c397-4a34-9bdd-35f4961db65b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/5daf7bfe-3945-4ea6-aa1e-215717746358, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/11404e89-f5d6-4e1b-ae92-f69f1f43b725, http://trials.drugis.org/entities/3ab8b9cb-e899-40cf-a5af-54e790264024, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/c5882e38-f158-4905-84c3-6f2012b31a18, http://trials.drugis.org/entities/cffd905f-557e-4042-853f-ceb8b79efa19, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/0cdc1f4d-4f3f-4f2d-bd8d-f6db15362df4, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/e9c623b1-7578-465d-8302-f1f5ccee7356" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/eaea4081-8da1-4c5b-96e0-aa3077adebca" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/eaea4081-8da1-4c5b-96e0-aa3077adebca" } ,
        "label": { "type": "literal" , "value": "TAK491-019 / NCT00696436" } ,
        "title": { "type": "literal" , "value": "An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension." } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/e201c136-3f31-46b5-b098-595cb367206a" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a6990ef5-7a65-4e9c-a5f5-583a9f9f32ef" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f33ac20-2fc5-427b-963e-d8668dc1f160" } ,
        "armLabel": { "type": "literal" , "value": "Valsartan 320 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Valsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/720f26be-b879-40ae-8937-ce2b4e8704e2" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/33a0eff6-f392-4804-b480-558a25baf515, http://trials.drugis.org/entities/faa2ac02-647d-448b-9ef4-b3319057dfa3, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/728ad883-6c95-4725-8425-910cd491a135, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/500779e0-7f4c-4e01-97f4-dc38d36ac915, http://trials.drugis.org/entities/95396b3a-1854-4719-9312-a8340f959edb, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/0760feb2-c397-4a34-9bdd-35f4961db65b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/5daf7bfe-3945-4ea6-aa1e-215717746358, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/11404e89-f5d6-4e1b-ae92-f69f1f43b725, http://trials.drugis.org/entities/3ab8b9cb-e899-40cf-a5af-54e790264024, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/c5882e38-f158-4905-84c3-6f2012b31a18, http://trials.drugis.org/entities/cffd905f-557e-4042-853f-ceb8b79efa19, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/0cdc1f4d-4f3f-4f2d-bd8d-f6db15362df4, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/e9c623b1-7578-465d-8302-f1f5ccee7356" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/eaea4081-8da1-4c5b-96e0-aa3077adebca" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/eaea4081-8da1-4c5b-96e0-aa3077adebca" } ,
        "label": { "type": "literal" , "value": "TAK491-019 / NCT00696436" } ,
        "title": { "type": "literal" , "value": "An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension." } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/6a2781ca-0a71-4dd1-98b4-d78817994476" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c4158912-96ec-4418-810a-345d73c9f778" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/3ef74c21-d1a3-43d8-b4cc-57e580fa2c9a" } ,
        "armLabel": { "type": "literal" , "value": "Olmesartan 40 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Olmesartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/e97e6e67-d3bf-4b60-ba51-fc2d9e91e50d" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/33a0eff6-f392-4804-b480-558a25baf515, http://trials.drugis.org/entities/faa2ac02-647d-448b-9ef4-b3319057dfa3, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/728ad883-6c95-4725-8425-910cd491a135, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/500779e0-7f4c-4e01-97f4-dc38d36ac915, http://trials.drugis.org/entities/95396b3a-1854-4719-9312-a8340f959edb, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/0760feb2-c397-4a34-9bdd-35f4961db65b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/5daf7bfe-3945-4ea6-aa1e-215717746358, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/11404e89-f5d6-4e1b-ae92-f69f1f43b725, http://trials.drugis.org/entities/3ab8b9cb-e899-40cf-a5af-54e790264024, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/c5882e38-f158-4905-84c3-6f2012b31a18, http://trials.drugis.org/entities/cffd905f-557e-4042-853f-ceb8b79efa19, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/0cdc1f4d-4f3f-4f2d-bd8d-f6db15362df4, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/e9c623b1-7578-465d-8302-f1f5ccee7356" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/eaea4081-8da1-4c5b-96e0-aa3077adebca" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/eaea4081-8da1-4c5b-96e0-aa3077adebca" } ,
        "label": { "type": "literal" , "value": "TAK491-019 / NCT00696436" } ,
        "title": { "type": "literal" , "value": "An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension." } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/5f8722f4-4c1a-41d6-a002-bd58c74def8a" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bb9cd83c-a8b4-4d31-8894-c1750a09e672" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/a769aafe-2edd-4526-a09a-459a28700c2e" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/33a0eff6-f392-4804-b480-558a25baf515, http://trials.drugis.org/entities/faa2ac02-647d-448b-9ef4-b3319057dfa3, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/728ad883-6c95-4725-8425-910cd491a135, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/500779e0-7f4c-4e01-97f4-dc38d36ac915, http://trials.drugis.org/entities/95396b3a-1854-4719-9312-a8340f959edb, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/0760feb2-c397-4a34-9bdd-35f4961db65b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/5daf7bfe-3945-4ea6-aa1e-215717746358, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/11404e89-f5d6-4e1b-ae92-f69f1f43b725, http://trials.drugis.org/entities/3ab8b9cb-e899-40cf-a5af-54e790264024, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/c5882e38-f158-4905-84c3-6f2012b31a18, http://trials.drugis.org/entities/cffd905f-557e-4042-853f-ceb8b79efa19, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/0cdc1f4d-4f3f-4f2d-bd8d-f6db15362df4, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/e9c623b1-7578-465d-8302-f1f5ccee7356" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/eaea4081-8da1-4c5b-96e0-aa3077adebca" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/eaea4081-8da1-4c5b-96e0-aa3077adebca" } ,
        "label": { "type": "literal" , "value": "TAK491-019 / NCT00696436" } ,
        "title": { "type": "literal" , "value": "An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension." } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/27637bd7-c215-411d-b419-5fb393605c38" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/d81355da-f0b5-4ff1-93b5-cfff0f32a399" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/98bf3e9e-2f90-4676-ad8a-2142780676bc" } ,
        "armLabel": { "type": "literal" , "value": "Placebo QD" } ,
        "drugLabel": { "type": "literal" , "value": "Placebo" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/5af90963-8999-4b6b-a71f-6a21872c649d" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/33a0eff6-f392-4804-b480-558a25baf515, http://trials.drugis.org/entities/faa2ac02-647d-448b-9ef4-b3319057dfa3, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/728ad883-6c95-4725-8425-910cd491a135, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/500779e0-7f4c-4e01-97f4-dc38d36ac915, http://trials.drugis.org/entities/95396b3a-1854-4719-9312-a8340f959edb, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/0760feb2-c397-4a34-9bdd-35f4961db65b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/5daf7bfe-3945-4ea6-aa1e-215717746358, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/11404e89-f5d6-4e1b-ae92-f69f1f43b725, http://trials.drugis.org/entities/3ab8b9cb-e899-40cf-a5af-54e790264024, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/c5882e38-f158-4905-84c3-6f2012b31a18, http://trials.drugis.org/entities/cffd905f-557e-4042-853f-ceb8b79efa19, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/0cdc1f4d-4f3f-4f2d-bd8d-f6db15362df4, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/e9c623b1-7578-465d-8302-f1f5ccee7356" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/eaea4081-8da1-4c5b-96e0-aa3077adebca" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/a795e3f0-325e-4172-973f-f25c34a5db96" } ,
        "label": { "type": "literal" , "value": "TAK491-008 / NCT00696241" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/7489d212-2d53-4bb7-b8ab-342b71edb507" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/50b0cb88-bfe1-4e59-9403-8667a6c7c923" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/813e9e43-16d4-4e5e-9c29-2ab5fdd50374" } ,
        "armLabel": { "type": "literal" , "value": "Olmesartan 40 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Olmesartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/e97e6e67-d3bf-4b60-ba51-fc2d9e91e50d" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/cd09b811-1a06-4d2e-b4b4-31701568eefd, http://trials.drugis.org/entities/31e45575-0dd6-4986-8cd3-3f2847f1b0e6, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/a7fb0b89-c0d8-45ce-b439-45bd51e43e92, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/535b6ea1-27a3-4c40-9c5b-1dd5722d8c6b, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/556bc804-144d-4325-a665-1ee44d9360de, http://trials.drugis.org/entities/4c785290-1214-4bdd-a59c-8f6fb63581aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/9f3a4336-4cbd-45eb-b608-8fb34421c00a, http://trials.drugis.org/entities/87cae8b8-7c4b-48f7-bdc7-3af0c9c93d1b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd, http://trials.drugis.org/entities/069ea7e5-5431-43b2-bd28-c9da1e30fee6, http://trials.drugis.org/entities/f1089b53-44c3-4317-bb7f-691c7f49a008, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/4d3fadcb-dc75-4d80-987a-48641f52d653, http://trials.drugis.org/entities/8e13d238-56ca-4be2-8943-61136dd6f25a, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/a795e3f0-325e-4172-973f-f25c34a5db96" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/a795e3f0-325e-4172-973f-f25c34a5db96" } ,
        "label": { "type": "literal" , "value": "TAK491-008 / NCT00696241" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/c3c23147-0325-4161-929d-f242a136af78" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/dbe5e2e6-566d-4d22-8a31-6498f60eb1b2" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/30275021-52c7-4e9e-90d9-e093afa421c1" } ,
        "armLabel": { "type": "literal" , "value": "Placebo QD" } ,
        "drugLabel": { "type": "literal" , "value": "Placebo" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/5af90963-8999-4b6b-a71f-6a21872c649d" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/cd09b811-1a06-4d2e-b4b4-31701568eefd, http://trials.drugis.org/entities/31e45575-0dd6-4986-8cd3-3f2847f1b0e6, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/a7fb0b89-c0d8-45ce-b439-45bd51e43e92, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/535b6ea1-27a3-4c40-9c5b-1dd5722d8c6b, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/556bc804-144d-4325-a665-1ee44d9360de, http://trials.drugis.org/entities/4c785290-1214-4bdd-a59c-8f6fb63581aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/9f3a4336-4cbd-45eb-b608-8fb34421c00a, http://trials.drugis.org/entities/87cae8b8-7c4b-48f7-bdc7-3af0c9c93d1b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd, http://trials.drugis.org/entities/069ea7e5-5431-43b2-bd28-c9da1e30fee6, http://trials.drugis.org/entities/f1089b53-44c3-4317-bb7f-691c7f49a008, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/4d3fadcb-dc75-4d80-987a-48641f52d653, http://trials.drugis.org/entities/8e13d238-56ca-4be2-8943-61136dd6f25a, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/a795e3f0-325e-4172-973f-f25c34a5db96" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/a795e3f0-325e-4172-973f-f25c34a5db96" } ,
        "label": { "type": "literal" , "value": "TAK491-008 / NCT00696241" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/e5fcdefc-8046-461b-ab54-074f088f6893" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/e69a6335-ea2d-4019-8a6e-8e55da1bfbdc" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/290a92aa-b5fd-4fbc-83ef-3b9df280009e" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/cd09b811-1a06-4d2e-b4b4-31701568eefd, http://trials.drugis.org/entities/31e45575-0dd6-4986-8cd3-3f2847f1b0e6, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/a7fb0b89-c0d8-45ce-b439-45bd51e43e92, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/535b6ea1-27a3-4c40-9c5b-1dd5722d8c6b, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/556bc804-144d-4325-a665-1ee44d9360de, http://trials.drugis.org/entities/4c785290-1214-4bdd-a59c-8f6fb63581aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/9f3a4336-4cbd-45eb-b608-8fb34421c00a, http://trials.drugis.org/entities/87cae8b8-7c4b-48f7-bdc7-3af0c9c93d1b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd, http://trials.drugis.org/entities/069ea7e5-5431-43b2-bd28-c9da1e30fee6, http://trials.drugis.org/entities/f1089b53-44c3-4317-bb7f-691c7f49a008, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/4d3fadcb-dc75-4d80-987a-48641f52d653, http://trials.drugis.org/entities/8e13d238-56ca-4be2-8943-61136dd6f25a, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/a795e3f0-325e-4172-973f-f25c34a5db96" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/a795e3f0-325e-4172-973f-f25c34a5db96" } ,
        "label": { "type": "literal" , "value": "TAK491-008 / NCT00696241" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/8e3f1fb0-ece4-450d-9174-30b293b2f8a2" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/2b0b43ce-02be-4ecf-85bb-17b130df5c2d" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/290a92aa-b5fd-4fbc-83ef-3b9df280009e" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/cd09b811-1a06-4d2e-b4b4-31701568eefd, http://trials.drugis.org/entities/31e45575-0dd6-4986-8cd3-3f2847f1b0e6, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/a7fb0b89-c0d8-45ce-b439-45bd51e43e92, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/535b6ea1-27a3-4c40-9c5b-1dd5722d8c6b, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/556bc804-144d-4325-a665-1ee44d9360de, http://trials.drugis.org/entities/4c785290-1214-4bdd-a59c-8f6fb63581aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/9f3a4336-4cbd-45eb-b608-8fb34421c00a, http://trials.drugis.org/entities/87cae8b8-7c4b-48f7-bdc7-3af0c9c93d1b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd, http://trials.drugis.org/entities/069ea7e5-5431-43b2-bd28-c9da1e30fee6, http://trials.drugis.org/entities/f1089b53-44c3-4317-bb7f-691c7f49a008, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/4d3fadcb-dc75-4d80-987a-48641f52d653, http://trials.drugis.org/entities/8e13d238-56ca-4be2-8943-61136dd6f25a, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/a795e3f0-325e-4172-973f-f25c34a5db96" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/a795e3f0-325e-4172-973f-f25c34a5db96" } ,
        "label": { "type": "literal" , "value": "TAK491-008 / NCT00696241" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/9359c0ac-20fb-4a91-9bf7-28cf91b7c643" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/dfd80068-030e-48ce-a525-2a731a201972" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/290a92aa-b5fd-4fbc-83ef-3b9df280009e" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 80 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/cd09b811-1a06-4d2e-b4b4-31701568eefd, http://trials.drugis.org/entities/31e45575-0dd6-4986-8cd3-3f2847f1b0e6, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/a7fb0b89-c0d8-45ce-b439-45bd51e43e92, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/535b6ea1-27a3-4c40-9c5b-1dd5722d8c6b, http://trials.drugis.org/entities/c0774e58-6fa5-498e-9494-a54a1c61b23d, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/556bc804-144d-4325-a665-1ee44d9360de, http://trials.drugis.org/entities/4c785290-1214-4bdd-a59c-8f6fb63581aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/9f3a4336-4cbd-45eb-b608-8fb34421c00a, http://trials.drugis.org/entities/87cae8b8-7c4b-48f7-bdc7-3af0c9c93d1b, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd, http://trials.drugis.org/entities/069ea7e5-5431-43b2-bd28-c9da1e30fee6, http://trials.drugis.org/entities/f1089b53-44c3-4317-bb7f-691c7f49a008, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/4d3fadcb-dc75-4d80-987a-48641f52d653, http://trials.drugis.org/entities/8e13d238-56ca-4be2-8943-61136dd6f25a, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/a795e3f0-325e-4172-973f-f25c34a5db96" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/733c8344-66d4-4137-b0e5-80762812be2f" } ,
        "label": { "type": "literal" , "value": "TAK491-301 / NCT00846365" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/a4c210fe-bd15-40fc-a6bc-54ad884d0d31" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/053d1df3-9972-4348-89b6-724f4c41ebb1" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/ad2a8fca-0faf-49f0-af98-12e94ecfc609" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/12bcfe09-84dc-4d42-8600-b0258649c10f, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/80f905c6-b737-4eb3-bc17-e68a97fc08f4, http://trials.drugis.org/entities/d82e550e-5508-43af-9ecb-1479d42162d8, http://trials.drugis.org/entities/62aaa93d-1b34-484f-82a4-c5802a98e23a, http://trials.drugis.org/entities/8d4bdd12-e2c1-42d5-89e0-90fe52ad0256, http://trials.drugis.org/entities/aee56100-b62c-42bb-a471-ed9b453fc168, http://trials.drugis.org/entities/4875e4c1-8972-437a-841a-252133fa2e57, http://trials.drugis.org/entities/18656c39-d78e-45f6-a74a-8a7c68ff02de, http://trials.drugis.org/entities/af0e5a74-3b56-4449-a278-83d254116d83, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/a6fed719-ecce-4950-930e-7cc63f397aea, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/824ea5bd-9832-41a7-b209-dc3a97017908, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2, http://trials.drugis.org/entities/35094eeb-7a21-412d-9d53-2946b6e5e1b9, http://trials.drugis.org/entities/9ebf6ebf-5931-4e41-a9c7-fa50c0c6728d, http://trials.drugis.org/entities/067f6a91-bfb1-4805-97e9-ea248eae6d4b, http://trials.drugis.org/entities/1778f946-5681-4906-9549-7cf3cdd76598, http://trials.drugis.org/entities/c3e98cdf-15c3-4842-8aff-e010a2c5a0cb, http://trials.drugis.org/entities/574cbf16-dfad-4556-b226-7b75c398b509, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/beeb425f-18b5-446c-8ea0-ad6663a2ab18, http://trials.drugis.org/entities/8ca2e61f-ddb7-45ef-acb3-c9f6bea843eb, http://trials.drugis.org/entities/fc2308fd-4038-46d3-bc43-7d5719663867, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/42226681-37bf-4e54-9578-2422c92ca1cd, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/11631e9f-e495-4279-92b8-612a24958819, http://trials.drugis.org/entities/cf6359b1-5f1b-4f69-bb01-bdff7842a104, http://trials.drugis.org/entities/94c2e0b6-2a3b-4f49-b7b0-35b181924301, http://trials.drugis.org/entities/af802309-ba14-4be3-ab94-a939ad5e38ba, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/9c16909c-e974-4328-aad6-2d6e2ce2d56a, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/36d9fafe-ba9c-43eb-866a-d99d8a1fcc7c, http://trials.drugis.org/entities/00933a0c-fd5e-4434-8ecb-ac4400e0429e, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/ded4b302-14b8-4170-9a17-131ee65fd6bb, http://trials.drugis.org/entities/8847aba9-0ff0-419b-9c71-f340864f733b, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/a21bf5b6-9458-4b1a-a135-b3372a293ca1, http://trials.drugis.org/entities/48f87603-56f3-45b6-ba78-e17fa792a071, http://trials.drugis.org/entities/9efab7e0-406e-4507-acd5-61a6ec482ecb, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/733c8344-66d4-4137-b0e5-80762812be2f" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/733c8344-66d4-4137-b0e5-80762812be2f" } ,
        "label": { "type": "literal" , "value": "TAK491-301 / NCT00846365" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/a4c210fe-bd15-40fc-a6bc-54ad884d0d31" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/053d1df3-9972-4348-89b6-724f4c41ebb1" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/3d14c53a-4247-4b8e-ab2e-3272cb0e43e1" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Chlortalidone" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/a310c936-a61f-44e8-a408-378ceaf2138c" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/12bcfe09-84dc-4d42-8600-b0258649c10f, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/80f905c6-b737-4eb3-bc17-e68a97fc08f4, http://trials.drugis.org/entities/d82e550e-5508-43af-9ecb-1479d42162d8, http://trials.drugis.org/entities/62aaa93d-1b34-484f-82a4-c5802a98e23a, http://trials.drugis.org/entities/8d4bdd12-e2c1-42d5-89e0-90fe52ad0256, http://trials.drugis.org/entities/aee56100-b62c-42bb-a471-ed9b453fc168, http://trials.drugis.org/entities/4875e4c1-8972-437a-841a-252133fa2e57, http://trials.drugis.org/entities/18656c39-d78e-45f6-a74a-8a7c68ff02de, http://trials.drugis.org/entities/af0e5a74-3b56-4449-a278-83d254116d83, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/a6fed719-ecce-4950-930e-7cc63f397aea, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/824ea5bd-9832-41a7-b209-dc3a97017908, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2, http://trials.drugis.org/entities/35094eeb-7a21-412d-9d53-2946b6e5e1b9, http://trials.drugis.org/entities/9ebf6ebf-5931-4e41-a9c7-fa50c0c6728d, http://trials.drugis.org/entities/067f6a91-bfb1-4805-97e9-ea248eae6d4b, http://trials.drugis.org/entities/1778f946-5681-4906-9549-7cf3cdd76598, http://trials.drugis.org/entities/c3e98cdf-15c3-4842-8aff-e010a2c5a0cb, http://trials.drugis.org/entities/574cbf16-dfad-4556-b226-7b75c398b509, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/beeb425f-18b5-446c-8ea0-ad6663a2ab18, http://trials.drugis.org/entities/8ca2e61f-ddb7-45ef-acb3-c9f6bea843eb, http://trials.drugis.org/entities/fc2308fd-4038-46d3-bc43-7d5719663867, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/42226681-37bf-4e54-9578-2422c92ca1cd, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/11631e9f-e495-4279-92b8-612a24958819, http://trials.drugis.org/entities/cf6359b1-5f1b-4f69-bb01-bdff7842a104, http://trials.drugis.org/entities/94c2e0b6-2a3b-4f49-b7b0-35b181924301, http://trials.drugis.org/entities/af802309-ba14-4be3-ab94-a939ad5e38ba, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/9c16909c-e974-4328-aad6-2d6e2ce2d56a, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/36d9fafe-ba9c-43eb-866a-d99d8a1fcc7c, http://trials.drugis.org/entities/00933a0c-fd5e-4434-8ecb-ac4400e0429e, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/ded4b302-14b8-4170-9a17-131ee65fd6bb, http://trials.drugis.org/entities/8847aba9-0ff0-419b-9c71-f340864f733b, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/a21bf5b6-9458-4b1a-a135-b3372a293ca1, http://trials.drugis.org/entities/48f87603-56f3-45b6-ba78-e17fa792a071, http://trials.drugis.org/entities/9efab7e0-406e-4507-acd5-61a6ec482ecb, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/733c8344-66d4-4137-b0e5-80762812be2f" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/733c8344-66d4-4137-b0e5-80762812be2f" } ,
        "label": { "type": "literal" , "value": "TAK491-301 / NCT00846365" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/7cfc98f6-c7bf-400a-a591-72d78ecc93c4" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5b9bb252-59d3-4936-a005-7ee443878c43" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/20bf70da-d53c-4959-a6a5-2bc87960c08a" } ,
        "armLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Olmesartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/e97e6e67-d3bf-4b60-ba51-fc2d9e91e50d" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/12bcfe09-84dc-4d42-8600-b0258649c10f, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/80f905c6-b737-4eb3-bc17-e68a97fc08f4, http://trials.drugis.org/entities/d82e550e-5508-43af-9ecb-1479d42162d8, http://trials.drugis.org/entities/62aaa93d-1b34-484f-82a4-c5802a98e23a, http://trials.drugis.org/entities/8d4bdd12-e2c1-42d5-89e0-90fe52ad0256, http://trials.drugis.org/entities/aee56100-b62c-42bb-a471-ed9b453fc168, http://trials.drugis.org/entities/4875e4c1-8972-437a-841a-252133fa2e57, http://trials.drugis.org/entities/18656c39-d78e-45f6-a74a-8a7c68ff02de, http://trials.drugis.org/entities/af0e5a74-3b56-4449-a278-83d254116d83, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/a6fed719-ecce-4950-930e-7cc63f397aea, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/824ea5bd-9832-41a7-b209-dc3a97017908, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2, http://trials.drugis.org/entities/35094eeb-7a21-412d-9d53-2946b6e5e1b9, http://trials.drugis.org/entities/9ebf6ebf-5931-4e41-a9c7-fa50c0c6728d, http://trials.drugis.org/entities/067f6a91-bfb1-4805-97e9-ea248eae6d4b, http://trials.drugis.org/entities/1778f946-5681-4906-9549-7cf3cdd76598, http://trials.drugis.org/entities/c3e98cdf-15c3-4842-8aff-e010a2c5a0cb, http://trials.drugis.org/entities/574cbf16-dfad-4556-b226-7b75c398b509, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/beeb425f-18b5-446c-8ea0-ad6663a2ab18, http://trials.drugis.org/entities/8ca2e61f-ddb7-45ef-acb3-c9f6bea843eb, http://trials.drugis.org/entities/fc2308fd-4038-46d3-bc43-7d5719663867, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/42226681-37bf-4e54-9578-2422c92ca1cd, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/11631e9f-e495-4279-92b8-612a24958819, http://trials.drugis.org/entities/cf6359b1-5f1b-4f69-bb01-bdff7842a104, http://trials.drugis.org/entities/94c2e0b6-2a3b-4f49-b7b0-35b181924301, http://trials.drugis.org/entities/af802309-ba14-4be3-ab94-a939ad5e38ba, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/9c16909c-e974-4328-aad6-2d6e2ce2d56a, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/36d9fafe-ba9c-43eb-866a-d99d8a1fcc7c, http://trials.drugis.org/entities/00933a0c-fd5e-4434-8ecb-ac4400e0429e, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/ded4b302-14b8-4170-9a17-131ee65fd6bb, http://trials.drugis.org/entities/8847aba9-0ff0-419b-9c71-f340864f733b, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/a21bf5b6-9458-4b1a-a135-b3372a293ca1, http://trials.drugis.org/entities/48f87603-56f3-45b6-ba78-e17fa792a071, http://trials.drugis.org/entities/9efab7e0-406e-4507-acd5-61a6ec482ecb, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/733c8344-66d4-4137-b0e5-80762812be2f" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/733c8344-66d4-4137-b0e5-80762812be2f" } ,
        "label": { "type": "literal" , "value": "TAK491-301 / NCT00846365" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/7cfc98f6-c7bf-400a-a591-72d78ecc93c4" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5b9bb252-59d3-4936-a005-7ee443878c43" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/f58bc40a-93ba-43f4-a377-35683f8c83d6" } ,
        "armLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Hydrochlorothiazide" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/1c36cc9e-34bc-4ba9-97bf-ffc2057c396b" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/12bcfe09-84dc-4d42-8600-b0258649c10f, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/80f905c6-b737-4eb3-bc17-e68a97fc08f4, http://trials.drugis.org/entities/d82e550e-5508-43af-9ecb-1479d42162d8, http://trials.drugis.org/entities/62aaa93d-1b34-484f-82a4-c5802a98e23a, http://trials.drugis.org/entities/8d4bdd12-e2c1-42d5-89e0-90fe52ad0256, http://trials.drugis.org/entities/aee56100-b62c-42bb-a471-ed9b453fc168, http://trials.drugis.org/entities/4875e4c1-8972-437a-841a-252133fa2e57, http://trials.drugis.org/entities/18656c39-d78e-45f6-a74a-8a7c68ff02de, http://trials.drugis.org/entities/af0e5a74-3b56-4449-a278-83d254116d83, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/a6fed719-ecce-4950-930e-7cc63f397aea, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/824ea5bd-9832-41a7-b209-dc3a97017908, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2, http://trials.drugis.org/entities/35094eeb-7a21-412d-9d53-2946b6e5e1b9, http://trials.drugis.org/entities/9ebf6ebf-5931-4e41-a9c7-fa50c0c6728d, http://trials.drugis.org/entities/067f6a91-bfb1-4805-97e9-ea248eae6d4b, http://trials.drugis.org/entities/1778f946-5681-4906-9549-7cf3cdd76598, http://trials.drugis.org/entities/c3e98cdf-15c3-4842-8aff-e010a2c5a0cb, http://trials.drugis.org/entities/574cbf16-dfad-4556-b226-7b75c398b509, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/beeb425f-18b5-446c-8ea0-ad6663a2ab18, http://trials.drugis.org/entities/8ca2e61f-ddb7-45ef-acb3-c9f6bea843eb, http://trials.drugis.org/entities/fc2308fd-4038-46d3-bc43-7d5719663867, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/42226681-37bf-4e54-9578-2422c92ca1cd, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/11631e9f-e495-4279-92b8-612a24958819, http://trials.drugis.org/entities/cf6359b1-5f1b-4f69-bb01-bdff7842a104, http://trials.drugis.org/entities/94c2e0b6-2a3b-4f49-b7b0-35b181924301, http://trials.drugis.org/entities/af802309-ba14-4be3-ab94-a939ad5e38ba, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/9c16909c-e974-4328-aad6-2d6e2ce2d56a, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/36d9fafe-ba9c-43eb-866a-d99d8a1fcc7c, http://trials.drugis.org/entities/00933a0c-fd5e-4434-8ecb-ac4400e0429e, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/ded4b302-14b8-4170-9a17-131ee65fd6bb, http://trials.drugis.org/entities/8847aba9-0ff0-419b-9c71-f340864f733b, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/a21bf5b6-9458-4b1a-a135-b3372a293ca1, http://trials.drugis.org/entities/48f87603-56f3-45b6-ba78-e17fa792a071, http://trials.drugis.org/entities/9efab7e0-406e-4507-acd5-61a6ec482ecb, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/733c8344-66d4-4137-b0e5-80762812be2f" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/733c8344-66d4-4137-b0e5-80762812be2f" } ,
        "label": { "type": "literal" , "value": "TAK491-301 / NCT00846365" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/0bf89dbb-f191-47d5-be9b-93be2b2ac41f" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a85a0aee-029e-485d-a1bb-f03bdb60fab3" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/3d14c53a-4247-4b8e-ab2e-3272cb0e43e1" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Chlortalidone" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/a310c936-a61f-44e8-a408-378ceaf2138c" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/12bcfe09-84dc-4d42-8600-b0258649c10f, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/80f905c6-b737-4eb3-bc17-e68a97fc08f4, http://trials.drugis.org/entities/d82e550e-5508-43af-9ecb-1479d42162d8, http://trials.drugis.org/entities/62aaa93d-1b34-484f-82a4-c5802a98e23a, http://trials.drugis.org/entities/8d4bdd12-e2c1-42d5-89e0-90fe52ad0256, http://trials.drugis.org/entities/aee56100-b62c-42bb-a471-ed9b453fc168, http://trials.drugis.org/entities/4875e4c1-8972-437a-841a-252133fa2e57, http://trials.drugis.org/entities/18656c39-d78e-45f6-a74a-8a7c68ff02de, http://trials.drugis.org/entities/af0e5a74-3b56-4449-a278-83d254116d83, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/a6fed719-ecce-4950-930e-7cc63f397aea, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/824ea5bd-9832-41a7-b209-dc3a97017908, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2, http://trials.drugis.org/entities/35094eeb-7a21-412d-9d53-2946b6e5e1b9, http://trials.drugis.org/entities/9ebf6ebf-5931-4e41-a9c7-fa50c0c6728d, http://trials.drugis.org/entities/067f6a91-bfb1-4805-97e9-ea248eae6d4b, http://trials.drugis.org/entities/1778f946-5681-4906-9549-7cf3cdd76598, http://trials.drugis.org/entities/c3e98cdf-15c3-4842-8aff-e010a2c5a0cb, http://trials.drugis.org/entities/574cbf16-dfad-4556-b226-7b75c398b509, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/beeb425f-18b5-446c-8ea0-ad6663a2ab18, http://trials.drugis.org/entities/8ca2e61f-ddb7-45ef-acb3-c9f6bea843eb, http://trials.drugis.org/entities/fc2308fd-4038-46d3-bc43-7d5719663867, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/42226681-37bf-4e54-9578-2422c92ca1cd, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/11631e9f-e495-4279-92b8-612a24958819, http://trials.drugis.org/entities/cf6359b1-5f1b-4f69-bb01-bdff7842a104, http://trials.drugis.org/entities/94c2e0b6-2a3b-4f49-b7b0-35b181924301, http://trials.drugis.org/entities/af802309-ba14-4be3-ab94-a939ad5e38ba, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/9c16909c-e974-4328-aad6-2d6e2ce2d56a, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/36d9fafe-ba9c-43eb-866a-d99d8a1fcc7c, http://trials.drugis.org/entities/00933a0c-fd5e-4434-8ecb-ac4400e0429e, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/ded4b302-14b8-4170-9a17-131ee65fd6bb, http://trials.drugis.org/entities/8847aba9-0ff0-419b-9c71-f340864f733b, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/a21bf5b6-9458-4b1a-a135-b3372a293ca1, http://trials.drugis.org/entities/48f87603-56f3-45b6-ba78-e17fa792a071, http://trials.drugis.org/entities/9efab7e0-406e-4507-acd5-61a6ec482ecb, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/733c8344-66d4-4137-b0e5-80762812be2f" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/733c8344-66d4-4137-b0e5-80762812be2f" } ,
        "label": { "type": "literal" , "value": "TAK491-301 / NCT00846365" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/0bf89dbb-f191-47d5-be9b-93be2b2ac41f" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a85a0aee-029e-485d-a1bb-f03bdb60fab3" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/ad2a8fca-0faf-49f0-af98-12e94ecfc609" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/12bcfe09-84dc-4d42-8600-b0258649c10f, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/80f905c6-b737-4eb3-bc17-e68a97fc08f4, http://trials.drugis.org/entities/d82e550e-5508-43af-9ecb-1479d42162d8, http://trials.drugis.org/entities/62aaa93d-1b34-484f-82a4-c5802a98e23a, http://trials.drugis.org/entities/8d4bdd12-e2c1-42d5-89e0-90fe52ad0256, http://trials.drugis.org/entities/aee56100-b62c-42bb-a471-ed9b453fc168, http://trials.drugis.org/entities/4875e4c1-8972-437a-841a-252133fa2e57, http://trials.drugis.org/entities/18656c39-d78e-45f6-a74a-8a7c68ff02de, http://trials.drugis.org/entities/af0e5a74-3b56-4449-a278-83d254116d83, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/a6fed719-ecce-4950-930e-7cc63f397aea, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/824ea5bd-9832-41a7-b209-dc3a97017908, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/18eff145-02f8-48e6-a844-fae7c591bca2, http://trials.drugis.org/entities/35094eeb-7a21-412d-9d53-2946b6e5e1b9, http://trials.drugis.org/entities/9ebf6ebf-5931-4e41-a9c7-fa50c0c6728d, http://trials.drugis.org/entities/067f6a91-bfb1-4805-97e9-ea248eae6d4b, http://trials.drugis.org/entities/1778f946-5681-4906-9549-7cf3cdd76598, http://trials.drugis.org/entities/c3e98cdf-15c3-4842-8aff-e010a2c5a0cb, http://trials.drugis.org/entities/574cbf16-dfad-4556-b226-7b75c398b509, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/7610e260-424f-4353-af1d-87b1c83ad6c5, http://trials.drugis.org/entities/beeb425f-18b5-446c-8ea0-ad6663a2ab18, http://trials.drugis.org/entities/8ca2e61f-ddb7-45ef-acb3-c9f6bea843eb, http://trials.drugis.org/entities/fc2308fd-4038-46d3-bc43-7d5719663867, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/42226681-37bf-4e54-9578-2422c92ca1cd, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/2669fc22-1c76-49a4-85d5-c832fdac09ce, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/11631e9f-e495-4279-92b8-612a24958819, http://trials.drugis.org/entities/cf6359b1-5f1b-4f69-bb01-bdff7842a104, http://trials.drugis.org/entities/94c2e0b6-2a3b-4f49-b7b0-35b181924301, http://trials.drugis.org/entities/af802309-ba14-4be3-ab94-a939ad5e38ba, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/d3298fed-2339-41f9-891d-6c7a0def32a1, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/9c16909c-e974-4328-aad6-2d6e2ce2d56a, http://trials.drugis.org/entities/df9be70b-dbdd-4063-aaea-5fc178451913, http://trials.drugis.org/entities/36d9fafe-ba9c-43eb-866a-d99d8a1fcc7c, http://trials.drugis.org/entities/00933a0c-fd5e-4434-8ecb-ac4400e0429e, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/ded4b302-14b8-4170-9a17-131ee65fd6bb, http://trials.drugis.org/entities/8847aba9-0ff0-419b-9c71-f340864f733b, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/a21bf5b6-9458-4b1a-a135-b3372a293ca1, http://trials.drugis.org/entities/48f87603-56f3-45b6-ba78-e17fa792a071, http://trials.drugis.org/entities/9efab7e0-406e-4507-acd5-61a6ec482ecb, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/3e6bfc45-57ea-4cdf-aa10-e45e0d3463cd" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/733c8344-66d4-4137-b0e5-80762812be2f" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/71a1408c-6718-4a11-a019-43ca5e8673ad" } ,
        "label": { "type": "literal" , "value": "TAK491-020 / NCT00760214" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/b59c6a19-9ff0-4522-9e26-84302bae4aa5" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/33c3381e-44ba-41f4-82e1-bd2c1008fdec" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/656c1586-dbee-4777-836c-43c8d4aa53d6" } ,
        "armLabel": { "type": "literal" , "value": "Ramipril 10 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Ramipril" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/7cf20b64-5a58-4176-9693-cd9a43f9cfcf" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/827870fe-6688-4f65-9de5-79308c14c254, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/95396b3a-1854-4719-9312-a8340f959edb, http://trials.drugis.org/entities/2a47b74c-d00c-4de3-bcc0-0b7891815cb1, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/aca049f7-532d-4d49-895b-80f12c1f62fc, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/3120db4d-1373-45ac-9dc8-69aaa650b3bd, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/bc7bcd7d-124b-4f4e-809f-acdbf5c92852, http://trials.drugis.org/entities/298d8406-caed-4003-bd76-980a1912b8e1, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/8e13d238-56ca-4be2-8943-61136dd6f25a, http://trials.drugis.org/entities/4d3fadcb-dc75-4d80-987a-48641f52d653, http://trials.drugis.org/entities/d709d2a9-7c91-40fc-8671-b95a2df87e74, http://trials.drugis.org/entities/b5ad2204-deb0-443e-b951-bd1024977eba, http://trials.drugis.org/entities/17a3f45c-0406-4fc8-a5cb-eb6d603f1608, http://trials.drugis.org/entities/6d1ff156-8f4e-41c4-8e21-5b07dd555ce2, http://trials.drugis.org/entities/57a9b1a7-3f0b-4e35-97ea-c39a7a1f4741, http://trials.drugis.org/entities/7857ebf4-72cd-4a9b-8e7c-7dd3b6ca6e3a, http://trials.drugis.org/entities/758994fe-b987-4b0a-bb34-fff271334180, http://trials.drugis.org/entities/31e45575-0dd6-4986-8cd3-3f2847f1b0e6, http://trials.drugis.org/entities/d87015c4-da3e-4c49-b138-c2ae4a9a980a, http://trials.drugis.org/entities/6ff463cf-f312-4b61-a1af-5397f7a348c0, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/351b7477-2147-4e51-b2f8-bdd05883fc68, http://trials.drugis.org/entities/9cf34e3e-d2c6-4b87-b3fa-70d67b789646, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/ed5fe073-a061-43d8-97fc-76f02b187d4a, http://trials.drugis.org/entities/b17e241d-4b95-44e1-8ef6-a53a1de0cf4f, http://trials.drugis.org/entities/4761d46d-44ed-4ac4-b33f-3cfcb957d70b, http://trials.drugis.org/entities/35094eeb-7a21-412d-9d53-2946b6e5e1b9, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/71a1408c-6718-4a11-a019-43ca5e8673ad" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/71a1408c-6718-4a11-a019-43ca5e8673ad" } ,
        "label": { "type": "literal" , "value": "TAK491-020 / NCT00760214" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/511107ec-779e-4c20-a1f9-0e196b1454bc" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/86c04c03-c3f3-43a9-9567-f63fce7e1c08" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/58c8a0b6-6c2e-4df1-835d-ebb0e236b976" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/827870fe-6688-4f65-9de5-79308c14c254, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/95396b3a-1854-4719-9312-a8340f959edb, http://trials.drugis.org/entities/2a47b74c-d00c-4de3-bcc0-0b7891815cb1, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/aca049f7-532d-4d49-895b-80f12c1f62fc, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/3120db4d-1373-45ac-9dc8-69aaa650b3bd, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/bc7bcd7d-124b-4f4e-809f-acdbf5c92852, http://trials.drugis.org/entities/298d8406-caed-4003-bd76-980a1912b8e1, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/8e13d238-56ca-4be2-8943-61136dd6f25a, http://trials.drugis.org/entities/4d3fadcb-dc75-4d80-987a-48641f52d653, http://trials.drugis.org/entities/d709d2a9-7c91-40fc-8671-b95a2df87e74, http://trials.drugis.org/entities/b5ad2204-deb0-443e-b951-bd1024977eba, http://trials.drugis.org/entities/17a3f45c-0406-4fc8-a5cb-eb6d603f1608, http://trials.drugis.org/entities/6d1ff156-8f4e-41c4-8e21-5b07dd555ce2, http://trials.drugis.org/entities/57a9b1a7-3f0b-4e35-97ea-c39a7a1f4741, http://trials.drugis.org/entities/7857ebf4-72cd-4a9b-8e7c-7dd3b6ca6e3a, http://trials.drugis.org/entities/758994fe-b987-4b0a-bb34-fff271334180, http://trials.drugis.org/entities/31e45575-0dd6-4986-8cd3-3f2847f1b0e6, http://trials.drugis.org/entities/d87015c4-da3e-4c49-b138-c2ae4a9a980a, http://trials.drugis.org/entities/6ff463cf-f312-4b61-a1af-5397f7a348c0, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/351b7477-2147-4e51-b2f8-bdd05883fc68, http://trials.drugis.org/entities/9cf34e3e-d2c6-4b87-b3fa-70d67b789646, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/ed5fe073-a061-43d8-97fc-76f02b187d4a, http://trials.drugis.org/entities/b17e241d-4b95-44e1-8ef6-a53a1de0cf4f, http://trials.drugis.org/entities/4761d46d-44ed-4ac4-b33f-3cfcb957d70b, http://trials.drugis.org/entities/35094eeb-7a21-412d-9d53-2946b6e5e1b9, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/71a1408c-6718-4a11-a019-43ca5e8673ad" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/71a1408c-6718-4a11-a019-43ca5e8673ad" } ,
        "label": { "type": "literal" , "value": "TAK491-020 / NCT00760214" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/23d88a88-bd13-4904-baa9-5668d0e43c6f" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/aac3b4f2-6f02-45b8-a128-5a9e61023c0d" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/58c8a0b6-6c2e-4df1-835d-ebb0e236b976" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 80 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/827870fe-6688-4f65-9de5-79308c14c254, http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/95396b3a-1854-4719-9312-a8340f959edb, http://trials.drugis.org/entities/2a47b74c-d00c-4de3-bcc0-0b7891815cb1, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/aca049f7-532d-4d49-895b-80f12c1f62fc, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/3120db4d-1373-45ac-9dc8-69aaa650b3bd, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/bc7bcd7d-124b-4f4e-809f-acdbf5c92852, http://trials.drugis.org/entities/298d8406-caed-4003-bd76-980a1912b8e1, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/8e13d238-56ca-4be2-8943-61136dd6f25a, http://trials.drugis.org/entities/4d3fadcb-dc75-4d80-987a-48641f52d653, http://trials.drugis.org/entities/d709d2a9-7c91-40fc-8671-b95a2df87e74, http://trials.drugis.org/entities/b5ad2204-deb0-443e-b951-bd1024977eba, http://trials.drugis.org/entities/17a3f45c-0406-4fc8-a5cb-eb6d603f1608, http://trials.drugis.org/entities/6d1ff156-8f4e-41c4-8e21-5b07dd555ce2, http://trials.drugis.org/entities/57a9b1a7-3f0b-4e35-97ea-c39a7a1f4741, http://trials.drugis.org/entities/7857ebf4-72cd-4a9b-8e7c-7dd3b6ca6e3a, http://trials.drugis.org/entities/758994fe-b987-4b0a-bb34-fff271334180, http://trials.drugis.org/entities/31e45575-0dd6-4986-8cd3-3f2847f1b0e6, http://trials.drugis.org/entities/d87015c4-da3e-4c49-b138-c2ae4a9a980a, http://trials.drugis.org/entities/6ff463cf-f312-4b61-a1af-5397f7a348c0, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/351b7477-2147-4e51-b2f8-bdd05883fc68, http://trials.drugis.org/entities/9cf34e3e-d2c6-4b87-b3fa-70d67b789646, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/ed5fe073-a061-43d8-97fc-76f02b187d4a, http://trials.drugis.org/entities/b17e241d-4b95-44e1-8ef6-a53a1de0cf4f, http://trials.drugis.org/entities/4761d46d-44ed-4ac4-b33f-3cfcb957d70b, http://trials.drugis.org/entities/35094eeb-7a21-412d-9d53-2946b6e5e1b9, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/71a1408c-6718-4a11-a019-43ca5e8673ad" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/ca86d376-6458-4ad1-acd0-00cf3e714115" } ,
        "label": { "type": "literal" , "value": "TAK491-011 / NCT00591253" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/ff21f357-22b3-431c-a6d0-658e351428b9" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/82320c63-41ee-4f77-9e3b-3b7314881bcf" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/d36f0637-4823-463e-bd18-ab06acf26144" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 80 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/11631e9f-e495-4279-92b8-612a24958819, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/3862036e-0355-4136-ad68-2a7180443e62, http://trials.drugis.org/entities/2bd34403-4dcb-4a54-ba20-bc3bd31ce3df, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/a21bf5b6-9458-4b1a-a135-b3372a293ca1, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/ca86d376-6458-4ad1-acd0-00cf3e714115" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/ca86d376-6458-4ad1-acd0-00cf3e714115" } ,
        "label": { "type": "literal" , "value": "TAK491-011 / NCT00591253" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/83ba3682-f8f8-4ed8-b4dc-ef4a92297458" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a4b3ea8e-d6e9-4f68-8cb0-ee0cd5e494dd" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/19427862-6ded-4745-a69d-692f9dfbca1a" } ,
        "armLabel": { "type": "literal" , "value": "Placebo QD" } ,
        "drugLabel": { "type": "literal" , "value": "Placebo" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/5af90963-8999-4b6b-a71f-6a21872c649d" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/11631e9f-e495-4279-92b8-612a24958819, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/3862036e-0355-4136-ad68-2a7180443e62, http://trials.drugis.org/entities/2bd34403-4dcb-4a54-ba20-bc3bd31ce3df, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/a21bf5b6-9458-4b1a-a135-b3372a293ca1, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/ca86d376-6458-4ad1-acd0-00cf3e714115" }
      } ,
      {
        "studyUri": { "type": "uri" , "value": "http://trials.drugis.org/studies/ca86d376-6458-4ad1-acd0-00cf3e714115" } ,
        "label": { "type": "literal" , "value": "TAK491-011 / NCT00591253" } ,
        "title": { "type": "literal" , "value": "Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension" } ,
        "activity": { "type": "uri" , "value": "http://trials.drugis.org/instances/4f8694e5-9a4b-45bb-9ace-16ba246f8e4f" } ,
        "armUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bc491cbc-64fc-4482-9c3c-a760e92f07b9" } ,
        "treatmentDrug": { "type": "uri" , "value": "http://trials.drugis.org/instances/d36f0637-4823-463e-bd18-ab06acf26144" } ,
        "armLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40 mg QD" } ,
        "drugLabel": { "type": "literal" , "value": "Azilsartan" } ,
        "drugUid": { "type": "uri" , "value": "http://trials.drugis.org/entities/40d2e6b0-56cc-434b-9199-fde1b5b9a6be" } ,
        "outcomeUids": { "type": "literal" , "value": "http://trials.drugis.org/entities/399b6814-8289-482b-87f7-ade143e42791, http://trials.drugis.org/entities/2c7f5c18-e7fc-45e5-8e63-2c90c31afaea, http://trials.drugis.org/entities/ab564cb0-189d-4b4b-9dde-0d8467d2d101, http://trials.drugis.org/entities/415e181e-4092-417e-ba05-3400c768f4c3, http://trials.drugis.org/entities/e4ab283d-e772-43dc-97e4-859c3af237aa, http://trials.drugis.org/entities/11631e9f-e495-4279-92b8-612a24958819, http://trials.drugis.org/entities/6c6f2ff8-dc52-40e1-9961-28ce3ca9dc99, http://trials.drugis.org/entities/4e78e897-fb96-4df3-89a8-ef6f4b6ba8e9, http://trials.drugis.org/entities/b7f2b80b-c3d3-41f3-8928-8d83d56da193, http://trials.drugis.org/entities/c17d6679-b99c-4a82-9c16-5c397540956b, http://trials.drugis.org/entities/3862036e-0355-4136-ad68-2a7180443e62, http://trials.drugis.org/entities/2bd34403-4dcb-4a54-ba20-bc3bd31ce3df, http://trials.drugis.org/entities/47c12782-a1d9-4415-a63b-d5cee621304e, http://trials.drugis.org/entities/f4376ddb-5609-4e2e-977c-3a637de61706, http://trials.drugis.org/entities/ce42fcf0-feed-47c6-84da-ab1147069185, http://trials.drugis.org/entities/d562c9a8-f131-4557-9bc2-bfc0193ebd53, http://trials.drugis.org/entities/6ba82676-818d-4201-8ad1-b38916539d74, http://trials.drugis.org/entities/f9de3efb-31b7-4c3d-a933-a6de7b7a65c9, http://trials.drugis.org/entities/3b2931e9-43b1-4fd9-bdcf-93e9aa48fd50, http://trials.drugis.org/entities/ddda96d4-60e9-4355-a035-c3cef389a62c, http://trials.drugis.org/entities/7370435b-b159-4c48-becd-bd7bd61b24ef, http://trials.drugis.org/entities/a21bf5b6-9458-4b1a-a135-b3372a293ca1, http://trials.drugis.org/entities/eb83dd95-c6a5-4b6f-886f-e31b4eaf146b, http://trials.drugis.org/entities/dc980b86-3991-4b78-b685-9afec4678842" } ,
        "studyGraphUri": { "type": "uri" , "value": "http://trials.drugis.org/graphs/ca86d376-6458-4ad1-acd0-00cf3e714115" }
      }
    ]
  }
}
